HydrochlorothiazideAntihypertensive AgentsSodium Chloride Symporter InhibitorsDiureticsHypertensionDrug CombinationsAmlodipineBlood PressureDrug Therapy, CombinationChlorthalidoneAtenololTriamtereneTetrazolesAngiotensin-Converting Enzyme InhibitorsCalcium Channel BlockersHydralazineThiazidesMethyldopaAngiotensin II Type 1 Receptor BlockersCaptoprilEnalaprilIndapamideBlood Pressure Monitoring, AmbulatoryBenzimidazolesLisinoprilLosartanDouble-Blind MethodAdrenergic beta-AntagonistsBenzothiadiazinesDrug SynergismBlood Pressure DeterminationRats, Inbred SHRTreatment OutcomeDrug InteractionsDoxazosinBendroflumethiazideTrichlormethiazideBiphenyl CompoundsAngiotensin Receptor AntagonistsValineFurosemideDose-Response Relationship, DrugReninHypertension, RenalBenzoatesUric AcidDihydropyridinesTime FactorsImidazolesClinical Trials as TopicCilazaprilSpironolactoneIndenesNifedipineNitrendipineFosinoprilRenin-Angiotensin SystemSystoleGuanabenzReserpineHypertrophy, Left VentricularTabletsClonidineSodium Chloride SymportersHeart RateMetoprololRisk FactorsKidneyBisoprololHypertension, RenovascularPatient ComplianceProspective StudiesPropranololRats, Inbred WKYFollow-Up StudiesDrug PrescriptionsCardiovascular DiseasesAldosteroneAcebutololRandom AllocationFumaratesMinoxidilDihydralazineDrug UtilizationRandomized Controlled Trials as TopicNordefrinEthacrynic AcidHypokalemiaAdrenergic alpha-AntagonistsAlbuminuriaDiastolePotassiumPulseAfrican Continental Ancestry GroupPhenoxyacetatesDrug EvaluationPropanolaminesSingle-Blind MethodDiuresisMedication Adherence